VRCA Verrica Pharmaceuticals Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Verrica Pharmaceuticals (VRCA) Stock: Buy, Sell, or Hold?

$3.72
-0.19 (-4.86%) â–ŧ
5d: +20.39% 30d: -2.87% 90d: -25.15%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (45%)
Quality Score
31/100
Position
FAIR
30-Day Fair Range
$3.32 – $3.97
Position: FAIR
Forward P/E & Valuation
-3.0x
Next 12M consensus est.
Wall Street Target
$13.83
+271.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.08 / $4.21
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: VRCA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When VRCA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: VRCA is currently trading at $3.72, which is considered fair relative to its 30-day fair value range of $3.32 to $3.97.

Technical Outlook: Technically, VRCA is in a strong downtrend. Immediate support is located at $3.08, while resistance sits at $4.21. Short-term momentum is weak, with the stock down 4.9% recently.

Market Sentiment: VRCA scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.83 (+271.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $3.32 - $3.97
Company Quality Score 31/100 (SELL)
Volume Confirmation HIGH
Confidence Score 44.7%

Trading Range & Key Levels

30-Day Trading Range $3.32 - $3.97
Current vs Trading Range FAIR
Support Level $3.08
Resistance Level $4.21
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (23/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.9%)
  • BULLISH: Trading 271.9% below Wall St target ($13.83)
  • WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -3.00
Wall Street Target $13.83 (+271.9%)
Revenue Growth (YoY) -53.9%
Profit Margin -102.8%
Share VRCA Analysis

Share this live VRCA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (VRCA)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 7, 2026
Daily AI digest
AI Retail Discussion Summary: Bearish sentiment dominates $VRCA on StockTwits, with one trader reporting a successful short position. No recent news articles were identified.
Key Retail Themes: Short selling Financial statements
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:10 PM ET
Data refreshes hourly during market hours. Next update: 8:10 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VRCA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals â€Ļ
STRONG BUY
30 analysts
$302 51 HOLD
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$438 30 SELL
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
ASND
Ascendis Pharma AS
STRONG BUY
21 analysts
$304 36 SELL
ORIC
Oric Pharmaceuticals Inc
STRONG BUY
15 analysts
$22 67 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive VRCA Research Pages
VRCA Technical Chart VRCA Price Prediction VRCA Intrinsic Value DCF VRCA Earnings Date VRCA Investment Advisor VRCA Fair Price Analyzer VRCA Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals